Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-10-18
2008-10-21
Campell, Bruce (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S350000, C530S402000
Reexamination Certificate
active
07439042
ABSTRACT:
Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.
REFERENCES:
patent: 4775622 (1988-10-01), Hitzeman et al.
patent: 5413914 (1995-05-01), Franzusoff
patent: 5641654 (1997-06-01), Maki et al.
patent: 5683864 (1997-11-01), Houghton et al.
patent: 5830463 (1998-11-01), Duke et al.
patent: 5858378 (1999-01-01), Bostwick
patent: 5871903 (1999-02-01), Miyamura et al.
patent: 5919651 (1999-07-01), Hitzeman et al.
patent: 5961978 (1999-10-01), Gaudernack et al.
patent: 6027729 (2000-02-01), Houghton et al.
patent: 6071693 (2000-06-01), Cha et al.
patent: 6074816 (2000-06-01), Houghton et al.
patent: 6090546 (2000-07-01), Breivik et al.
patent: 6121020 (2000-09-01), Selby et al.
patent: 6187307 (2001-02-01), Cohen
patent: 6194140 (2001-02-01), Houghton et al.
patent: 6284249 (2001-09-01), Barban
patent: 6326171 (2001-12-01), Selby et al.
patent: 6361969 (2002-03-01), Galeotti
patent: 6521423 (2003-02-01), Houghton et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6562346 (2003-05-01), Paliard et al.
patent: 6759046 (2004-07-01), Gaudemack et al.
patent: 6861057 (2005-03-01), Gaudemack et al.
patent: 6890737 (2005-05-01), Maertens et al.
patent: 6986892 (2006-01-01), Coit et al.
patent: 7048930 (2006-05-01), Bosman et al.
patent: 7083787 (2006-08-01), Duke et al.
patent: 2002/0004048 (2002-01-01), Ralston et al.
patent: 2003/0035810 (2003-02-01), Caplan
patent: 2003/0064499 (2003-04-01), Houghton et al.
patent: 2003/0108561 (2003-06-01), Bosman et al.
patent: 2003/0129586 (2003-07-01), Houghton et al.
patent: 2003/0152940 (2003-08-01), Sablon et al.
patent: 2004/0009937 (2004-01-01), Chen et al.
patent: 2004/0072759 (2004-04-01), Gaudemack et al.
patent: 2004/0151735 (2004-08-01), Maertens et al.
patent: 2004/0156858 (2004-08-01), Franzusoff et al.
patent: 2005/0013828 (2005-01-01), George et al.
patent: 2005/0074465 (2005-04-01), Houghton
patent: 2005/0074849 (2005-04-01), Gaudemack et al.
patent: 2486400 (1980-01-01), None
patent: WO 9222571 (1992-12-01), None
patent: WO 02/39951 (2002-05-01), None
patent: WO 2004/005473 (2004-01-01), None
patent: WO 2004/046175 (2004-06-01), None
patent: WO 2004/046176 (2004-06-01), None
patent: WO 2004/058157 (2004-07-01), None
Matsui et al (2002) Vaccine. 21: 211-220.
O'Brien et al (2000) Protein Sci. 9: 570-579.
Lechmann and Liang (2000) Semin Liver Dis. 20(2): 211-26.
Acosta-Rivero et al., 2002,Biochemical and Biophysical Research Com., 295: 81-84.
Adams et al., 1994,International Reviews of Immunology, 11(2) : 133-141.
Allsopp et al., 1996,European Journal of Immunology, 26(8): 1951-1959.
Bachmann et al., 1994,Curr. Op. Immunol., 6:320-326.
Baker et al., 1988,Cell, 54:335-344.
Bizzini et al., 1990,FEMS Microbiol. Immunol., 64:155-168.
Bourdette et al., 1994,J. Immunol., 152:2510-2519.
Brake et al., 1984,Proc. Natl. Acad. Sci. USA, 81:4642-4646.
Brossier et al., 1999,Infection and Immunity, 67(2): 964-967.
Brown, D., 1995,The Washington Post, “Gene Therapy ‘Oversold’ by Researchers, Journalists”.
Chien et al., 1992,Proc. Natl. Acad Sci. USA., 89:10011-10015.
Chou et al., 1994,J. Immunol., 152:2520-2529.
Coghlan, 1995,New Scientists, 145:14-15.
Cohen, 1994,Science, 264:1660.
Cohen, 1994,Science, 264:1839.
Davies et al., 1992,Nucleic Acids Res., 20(11):2693-2698.
Demmer et al., 1993,J. Immunol., 150(12):5371-5378.
Engelhardt et al., 1994,Hum. Gene Ther, 5:1217-1229.
Fattal-German et al., 1992,Develop. Biol. Standard., 77:115-120.
Franzusoff et al., 1995,J. Biol. Chem., 270(7):3154-3159.
Fujita et al., 1987,Bulletin of the World Health Organization, 65(3):303-308.
Garber et al., 2003,AIDS Reviews, 5(3):131-139.
Gnirke et al., 1991,EMBO J., 10(7):1629-1634.
Gobin et al., 1995,Gene, 163:27-33.
Hatsuyama et al., 1994,Plant Cell Physiol., 35(1):93-98.
Kaur et al., 2003,Topics in HIV Medicine, 11(3): 76-85.
Ketner et al., 1994,Proc. Natl. Acad. Sci. USA, 91:6186-6190.
Khu et al., 2004,Biochem. J., 384:401-409.
Layton et al., 1996,Immunology, 87(2):171-178.
Markie et al., 1993,Somat. Cell Mol. Genet., 19(2):161-169.
Markland et al., 1997,Journal of General Virology., 78:39-43.
Marshall, 1995,Science269:1050-1055.
Martinez-Donato et al., 2006,Biochemical and Biophysical Research Comm., 342:625-631.
Moore, et al., 1996,FASEB J., 10(6) Abstract 2725.
Moulard et al., 1994,Eur. J. Biochem. 225:565-572.
Mullen et al., 1994,Plant Physiol., 105:113 (Abstr. 606).
Mulligan, 1993,Science, 260:926-931.
Mustilli et al., 1999,Res. Microbiol., 150:179-187.
Pachnis et al., 1990,Proc. Natl. Acad. Sci. USA, 87:5109-5113.
Paglia et al., 1996,Journal of Experimental Medicine, 183(1):317-322.
Parolin et al., 2005,Journal of Biotechnology, 120:45-58.
Peterson et al., 1993,Proc. Natl. Acad. Sci. USA, 90:11207-11211.
Rabinovich et al., 1994,Science, 265:1401-1404.
Rosa et al., 1996,Proc. Natl. Acad. Sci. USA, 93:1759-1763.
Sanchez-Pescador et al., 1985,Science, 227:484-492.
Schreuder et al., 1996Vaccine, 14(5):383-388.
Schupper et al., 1993,Hepatology, 18(5):1055-1060.
Sousa et al., 1993,Journal of Experimental Medicine, 178(2):509-519.
Stern et al., 1992,Cell, 68:465-477.
Suda et al., 1993,Cell, 75:1169-1178.
Valenzuela et al., 1985,Biol Technology, 3:323-326.
Genpept AAB67036, “polyprotein [Hepatitis C virus strain H77]”, Aug. 16, 1997.
Park et al., “Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.” Journal of Korean medical science, Apr. 1999, vol. 14, No. 2, pp. 165-170.
Seong et al., “Overexpression and simple purification of a truncated immunologically reative GST-HCV core (1-123) fusion protein”, Journal of Virological Methods, May 1996, vol. 59, Nos. 1-2, pp. 13-21.
International Search Report for International (PCT) Patent Application No. PCT/US05/37499, mailed Jan. 11, 2008.
Written Opinion for International (PCT) Patent Application No. PCT/US05/37499, mailed Jan. 11, 2008.
Duke Richard C.
Franzusoff Alex
Haller Aurelia
King Thomas H.
Campell Bruce
GlobeImmune, Inc.
Horning Michelle
Sebor Angela Dallas
Sheridan & Ross P.C.
LandOfFree
Yeast-based therapeutic for chronic hepatitis C infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Yeast-based therapeutic for chronic hepatitis C infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Yeast-based therapeutic for chronic hepatitis C infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4010840